Unique ID issued by UMIN | UMIN000049961 |
---|---|
Receipt number | R000056904 |
Scientific Title | A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy |
Date of disclosure of the study information | 2023/01/10 |
Last modified on | 2024/09/18 09:29:38 |
A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy
A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy
A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy
A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy
Japan |
Diseases in the pancreatic head region
Hepato-biliary-pancreatic surgery |
Malignancy
NO
Consideration the safety and usefulness of using stapler for transection of pancreatic parenchyma during pancreaticoduodenectomy
Safety,Efficacy
Confirmatory
the rate of postoperative pancreatic fistula (ISGPF; GradeB or C)
Observational
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1)Patients judged to have a normal pancreas among those scheduled for pancreaticoduodenectomy.
2) The thickness of the pancreatic parenchyma can be cut with an automatic suturer.
3) ECOG Performance Status (PS) is 0-1.
4) Age over 20 years old.
5) The functions of major organs (bone marrow, heart, liver, kidney, lung, etc.) are maintained.
6) Has sufficient judgment to understand the content of the research, and has obtained written informed consent from the individual.
1) Patients with severe ischemic heart disease
2) Patients with cirrhosis or active hepatitis
3) Patients with dyspnea requiring oxygen administration due to interstitial pneumonia or pulmonary fibrosis
4) Patients undergoing dialysis for chronic renal failure
5) Cases requiring combined resection of surrounding organs
6) Patients considered to require arterial reconstruction of the superior mesenteric artery, common hepatic artery, celiac artery, etc.
7) Active double cancer that may affect adverse events or overall survival
8) Long-term oral steroid use that may affect adverse events
9) Patients who are complicated by psychosis or psychiatric symptoms and judged to be difficult to participate in the study
10) History of gastrectomy, colectomy or rectal resection
11) Patients who cannot use both iodine-based drugs and gadonium-based drugs due to severe drug allergies
15
1st name | Yuji |
Middle name | |
Last name | Kitahata |
Wakayama medical university
2nd department of surgery
641-8510
811-1 Kimiidera Wakayama
0734410613
yuji-kh@wakayama-med.ac.jp
1st name | Yuji |
Middle name | |
Last name | Kitahata |
Wakayama medical university
2nd department of surgery
641-8510
811-1 Kimiidera Wakayama
0734410613
yuji-kh@wakayama-med.ac.jp
Wakayama medical university
Wakayama medical university
Other
Wakayama medical university
811-1 Kimiidera Wakayama
9734472300
yuji-kh@wakayama-med.ac.jp
NO
2023 | Year | 01 | Month | 10 | Day |
Unpublished
Completed
2022 | Year | 09 | Month | 01 | Day |
2023 | Year | 01 | Month | 16 | Day |
2022 | Year | 09 | Month | 01 | Day |
2023 | Year | 06 | Month | 30 | Day |
2023 | Year | 06 | Month | 30 | Day |
2023 | Year | 06 | Month | 30 | Day |
2023 | Year | 06 | Month | 30 | Day |
not particular
2023 | Year | 01 | Month | 04 | Day |
2024 | Year | 09 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056904